Objective Uncertainty exists when relying on office (clinic) blood pressure (BP) measurements to diagnose hypertension. Home BP monitoring and ambulatory BP monitoring (ABPM) provide measurements that are more strongly associated with cardiovascular disease. The degree to which patients exhibit uncertainty about office BP measurements is unknown, as is whether they would have less uncertainty about other BP measurement methods. We therefore assessed people's confidence in methods of BP measurement, comparing perceptions about office BP monitoring, home BP monitoring, and ABPM techniques.
Introduction
Controlling hypertension is the single most effective clinical service for reducing overall mortality [1] . Unfortunately, only half of the people with hypertension have their blood pressure (BP) under control [2] . Among the modifiable factors known to be associated with poor BP control, suboptimal therapy plays a substantial role [3, 4] . Suboptimal therapy is often due to clinical inertiathat is, the failure of clinicians to initiate or intensify antihypertensive therapy despite elevated BP levels. One of the factors that play a role in clinical inertia is clinical uncertainty [5] . Clinical uncertainty partly reflects the fact that clinicians appreciate that clinic (office) BP assessments can be a poor gauge of a patient's true BP status, for example, because of inherent variability or the white-coat effect [6] . Indeed, ambulatory BP monitoring (ABPM) has demonstrated this to be the case [7] [8] [9] .
It is likely that patients also have some uncertainty about clinic BP measurements. It is not uncommon for patients to use home BP monitors or monitors stationed in pharmacies to check their BP, and such measurements may vary markedly from clinic BP measurements [10, 11] . Patients may also have observed the hurried manner in which clinic BP measurements might have be made, or may have observed a lower BP recorded when the measurement was repeated later during the same clinic visit. A patient's lack of confidence in the BP measurement on the basis of which clinical decisions are made may translate into failure to believe that medications are needed, which in turn may lead to patients not initiating or persisting with the use of medications.
To our knowledge, no prior research has sought to systematically examine the confidence people place in BP measurements or whether patients' confidence in measurements of their BP varies by method of assessment. We therefore developed an instrument that can be used Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (www.bpmonitoring.com).
to assess people's confidence in methods of BP measurement. Specifically, our goal was to be able to compare perceptions about office (clinic) BP monitoring, home BP monitoring, and ABPM techniques.
Methods

Initial questionnaire development
We created a draft instrument on the basis of a previously validated credibility and expectancy questionnaire [12] . We tailored the items for the purpose of assessing respondents' beliefs about the types of BP measurements, creating versions that mirrored each other for office BP monitoring, home BP monitoring, and ABPM.
Focus group
After the initial instrument was created, we held a focus group with eight people who had previously participated in a research study in which they had undergone several office BP measurements and had worn a validated 24-h ambulatory BP monitor on two occasions 1 week apart. They had also performed home BP monitoring for five consecutive days per week over 2 weeks. Details of this BP measurement study have been published previously [13] . During the focus group, we asked the participants to complete the questionnaire, taking careful notes as they read and responded to the questions.
Refinement and review by experts
The revised instrument was then reviewed by experts in clinical hypertension, practicing clinicians, a biostatistician, and an expert in health communication at our quarterly Hypertension Research Program meeting. On the basis of feedback, we made further revisions to some of the items, to create our final version (Appendix, Supplemental digital content 1, http://links.lww.com/BPMJ/A16).
Survey implementation
We mailed paper versions of the questionnaire consisting of office BP monitoring and ABPM items to 408 adults who were 30 years or older and had previously participated in the BP measurement study described above. Approximately 3 months later, we mailed the same questionnaire with the addition of home BP monitoring questionnaire items to a random sample of 50 people from among those who had returned the first set of questionnaires, with a gift card for coffee included as a small incentive.
Variables
Our main outcome of interest was self-reported confidence in the methods of BP assessment on a scale from 1 (not at all confident) to 9 (very confident). We included similar items on confidence that the measurements are successful in obtaining a diagnosis (of hypertension) and on confidence in the need to take medications (or not) on the basis of the measurements. We also included questions on the perceived accuracy of office BP compared with ambulatory BP measurements, and the expected improvement in BP in response to treatment based on the BP measurement method. To allow comparisons by patient characteristics, we also included demographic items, numeracy level using a previously validated scale [14] , and office and ambulatory BP levels.
Analysis
We first examined missing item patterns. Next, we produced summary statistics for each item. For continuously measured response variables, we took note of the minimum and maximum values, the 25th and 75th percentiles, the means, and the medians. We examined test-retest reliability in a subsample using the intraclass correlation coefficient. For categorical responses, we noted percent responding in each category.
Because reports of confidence on the 1-9 scale were skewed, we reported medians for these variables and compared any observed difference between methods using Wilcoxon's signed-rank test and any difference across categorical variables using the Kruskal-Wallis test.
Results
Characteristics of the sample
A total of 193 people returned the initial questionnaire. A total of 43 (of 50) returned the repeat questionnaire containing the home BP monitoring items. The mean age of the 193 total respondents was 50 years: 43% were men and 83% were white (Table 1 ). Approximately 28% had Table 2 , Supplemental digital content 3, http://links.lww.com/BPMJ/A14) were skewed. The interquartile ranges for office BP items were much wider than those for ABPM or home BP measurements. The medians and means for ABPM and home BP measurement items were higher than those for office BP measurement items.
Test-retest reliability
In the subsample (N = 43) , the test-retest reliability of the office and ABPM sets of items was high, as evidenced by their intraclass correlation coefficients, ranging from 0.72 to 0.88 (Supplemental Table 3 , Supplemental digital content 4, http://links.lww.com/BPMJ/A15).
Confidence in blood pressure assessment methods
As shown in Fig. 1 , respondents had least confidence that assessments of BP made by office measurements represented their usual BP and greatest confidence that assessments made by ABPM did so (median 8 vs. 6, P < 0.0001). A similar pattern was seen for confidence that measurements were successful in determining a diagnosis. In both of these confidence assessments, home BP assessments received a greater vote of confidence than office BP assessments (median 7 vs. 6; P < 0.0001), but neither fared as well as ABPM. For confidence in the need to take medicines on the basis of measurements, home BP monitoring slightly edged out ABPM (median 8 vs. 7), but the difference was not statistically significant (P = 0.43).
Confidence levels did not vary significantly by age, sex, race, or education level ( Table 2) . Those with a lower numeracy level were more likely to have higher confidence in office BP measurements (median 7 vs. 5; P = 0.0001). Even when a discrepancy existed, such as nonelevated office BP but elevated average ambulatory BP (i.e. masked hypertension), confidence was not affected.
Overall perceptions of comparative accuracy between office and ambulatory BP measurement are shown in Table 3 . Most respondents (60%) believed ABPM to be a lot more accurate than office BP monitoring. Approximately 8% indicated that neither is accurate.
Likelihood of taking medication, and expected improvement
Most respondents indicated that they expected at least some improvement in their BP if they were to take medication on the basis of any of the methods of measurement (Table 4 ). However, they indicated a greater expectancy of a significant improvement and a greater likelihood of actually taking the medications in the case of elevated BP on home BP monitoring or ABPM. On a scale from 1 to 9, the median reported likelihood was 6 for office BP versus 8 for both home and ambulatory BP (data not shown).
The majority of respondents (78%) indicated that they would be more willing to take BP-lowering medication if the high office BP measurement was confirmed by ABPM ( Table 5 ). Slightly more than half (52%) of the respondents indicated definite willingness to take medication even if office BP measurements were not elevated but the average ambulatory BP measurement was elevated.
Discussion
We sought to compare patients' confidence in three main methods of BP assessment. Importantly, we found that patients have greater confidence in assessments of their BP status made by ambulatory and home BP monitoring as opposed to office BP measurements. This information is useful because home and ambulatory BP measurements have been shown to predict cardiovascular events better than office BP measurements [9] . Thus, patients seem to have greater confidence in methods that actually are more valid assessments of their BP in relation to prognosis.
Office BP measurements are fraught with potential error. The proper technique for measurement of BP is often not followed, or measurements are taken in a hurry in an effort to be efficient in busy clinical practices [15] . ABPM is now considered the reference standard for diagnosing hypertension [8, 9] . Both the NICE guidelines (UK) and, more recently, the United States Preventive Services Task Force recommend ABPM to confirm the diagnosis of hypertension, with substitution by home BP monitoring if ABPM is not available [16, 17] . Our findings suggest that a potential added benefit of this strategy will be that patients will be more confident of the diagnosis of hypertension.
In addition to being more confident of ambulatory BP and home BP assessments, respondents also indicated greater confidence in the need to take medication on the basis of the measurements. This confidence may translate into better medication adherence. A small, but not Confidence measurements represent usual BP
Confidence measurements successful in determining diagnosis
Confidence in need to take medication based on measurements
Office Home Ambulatory
Confidence in BP measurement methods. P < 0.0001 for all comparisons of office versus home and office versus ambulatory BP measurements. Difference between home and ambulatory BP measurements were not significant. Bars show the interquartile range. For example, the median value for confidence that measurements represent usual BP for office measurements was 6, with the 25th percentile at 3 and the 75th percentile at 7. BP, blood pressure. P-value calculated by Kruskal-Wallis test, shown only for categories for which there was a difference in the median value. For example, as there was no difference in the median value of confidence in office BP measurements between those with and without masked hypertension, the P-value of 1 is not shown. BP, blood pressure.
insignificant, proportion of respondents appeared to lack confidence in both office and ambulatory BP measurements and refused to take medication regardless of the detected elevation in BP. This 'no confidence' group did not differ from the remaining respondents in terms of age, sex, race, office BP level, or ambulatory BP level. However, they did have a lower numeracy level (data not shown).
We also observed that, overall, respondents with a lower numeracy level were more likely to have higher confidence in office BP measurements. This finding suggests that the value of multiple measurements (as obtained with ambulatory or home BP monitoring) and their use in providing a BP average may need to be more greatly emphasized to some patients. Future research could also compare the effectiveness of various methods of depicting ambulatory and home BP results, for example, in a tabular versus a graphical form.
Another learning point that should not be overlooked is that respondents indicated greater confidence in ABPM even when the office BP measurement was not elevated.
More than half of the participants indicated willingness to take BP medications if ambulatory BP was elevated, even if the office BP measurement was not elevated. Such 'masked hypertension' is associated with target-organ damage and cardiovascular events [18] . Although it is not yet known whether treatment of masked hypertension improves cardiovascular outcomes, our finding that patients would be willing to consider medications based solely on ABPM is a valuable one.
Limitations
This study is the first we know of that examines people's confidence in BP assessment methods. However, we acknowledge several limitations. First, our sample was not necessarily representative of the general population of clinic patients. Our respondents based their experience with ABPM on a research protocol, which may be different from actual clinical experience. Importantly though, the processes were all standardized such that approaches to BP monitoring were the same for all respondents. The study participants also had a high prevalence of ambulatory hypertension, as described previously [13] . However, we would have expected this finding to bias responses less in favor of ABPM. Thus, in a more representative sample (e.g. with a higher prevalence of white-coat hypertension), the ratings may actually be more strongly in favor of ABPM. Another limitation is that we only collected data on home BP measurement comparisons from a subsample of the respondents. Finally, we did not examine actual medication initiation or adherence.
Conclusion
Both the clinician and the patient must believe that whatever measurement they are relying on to manage BP is an accurate reflection of the patient's usual BP. We found that patients do not have a great deal of confidence in office BP measurements, but have a much higher degree of confidence in home BP and ambulatory BP assessment methods. Future research in more generally representative samples should be conducted and should examine whether this greater confidence is associated with better medication adherence.
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